What is BOVNF's gross margin?

BioInvent (BOVNF) has a gross margin of 100% and a net margin of -964%.

What is BOVNF's P/E ratio?

Track BioInvent (BOVNF) P/E ratio, ROE, and valuation metrics over time.

Where can I see BOVNF's full financials?

See BioInvent (BOVNF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

BioInvent (BOVNF) Financials — Revenue, Earnings, Cash Flow

Also trades as: BINV.ST (STO) · $vol 0M · 0H22.L (LSE) · $vol 0M

$3.29

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 37 · $216.4M mcap · 48M float · 0.0016% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$32M

Revenue

-87.2% YoY

$-496M

Net Income

-70.0% YoY

$-442M

Free Cash Flow

-72.8% YoY

100.0%

Gross Margin

-980.6%

Op. Margin

-964.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-88.2%

ROA-74.2%

ROIC20101.5%

Valuation

P/E-3.0

P/B4.7

EV/EBITDA0.0

Leverage

Debt/Equity0.07

Current Ratio4.06

Interest Cov.0.0x

Quality Scores

Piotroski F1/9

Altman Z—

Beneish M-1.48